Early Rheumatoid Arthritis Clinical Trial
Official title:
Effect of Early Intensive Treatment in Chinese Patients With Recent-onset Rheumatoid Arthritis
To compare the effectiveness of two treatment strategies in early rheumatoid arthritis (ERA), namely the delayed usual care and early intensive care, in Hong Kong. - The delayed usual care reflects the usual treatment practice in Hong Kong - The early intensive care includes tight monitoring and immediate adjustment of therapy
This study is a 1-year non-randomized clinical trial. Two groups of patients (delayed usual care and early intensive care) with diagnosis of rheumatoid arthritis (RA) and with symptoms onset of less than 2 years and disease modifying anti-rheumatic drugs (DMARDs) naive will be recruited. Remission is reached if patients fulfill the Boolean criteria. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01768923 -
Early RA Vascular Randomised Controlled Study
|
N/A | |
Completed |
NCT01185301 -
Study to Determine the Effects of Different Doses of Methotrexate (MTX) When Taken With Adalimumab in Subjects With Early Rheumatoid Arthritis (RA)
|
Phase 3 | |
Recruiting |
NCT03755258 -
Trial of Ginsenoside Compound K (GCK) Tablet in Patients With Rheumatoid Arthritis
|
Phase 1 | |
Recruiting |
NCT03389711 -
INCMNSZ - Rheumatoid Arthritis Cohort
|
||
Completed |
NCT00195663 -
Efficacy and Safety of Adalimumab and Methotrexate (MTX) Versus MTX Monotherapy in Subjects With Early Rheumatoid Arthritis
|
Phase 3 | |
Completed |
NCT04752748 -
Power Doppler in Hand Joints of Early RA Patients
|